Carlo Salvarani
About
In The Last Decade
Carlo Salvarani
575 papers receiving 23.4k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Rheumatology 14.3k
- Pulmonary and Respiratory Medicine 13.7k
- Genetics 4.5k
- Immunology 4.1k
- Ophthalmology 2.7k
Countries citing papers authored by Carlo Salvarani
This map shows the geographic impact of Carlo Salvarani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Salvarani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Salvarani more than expected).
Fields of papers citing papers by Carlo Salvarani
This network shows the impact of papers produced by Carlo Salvarani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Salvarani. The network helps show where Carlo Salvarani may publish in the future.
Co-authorship network of co-authors of Carlo Salvarani
This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Salvarani. A scholar is included among the top collaborators of Carlo Salvarani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Salvarani. Carlo Salvarani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 18 | |
| 7 | 18 | |
| 8 | 0 | |
| 9 | 1 | |
| 10 | 17 | |
| 11 | 12 | |
| 12 | 12 | |
| 13 | 10 | |
| 14 | 6 | |
| 15 | Imbalance between angiogenic and anti-angiogenic factors in sera from patients with large-vessel vasculitis. | 14 |
| 16 | Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study. | 11 |
| 17 | Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? | 22 |
| 18 | Efficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre. | 8 |
| 19 | The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept. | 43 |
| 20 | Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis. | 33 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.